Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

infectious · Mechanism Report

Does a negative blood PCR for Borrelia rule out infection or tissue persistence?

A negative blood PCR for Borrelia does not rule out infection and does not show whether Borrelia persists in tissue.

SupportedSeptember 22, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Blood PCR for Borrelia has limited sensitivity because organisms may be sparse in blood, so a negative result does not exclude infection; however, it also does not demonstrate tissue persistence.

laying out figure…
0 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says blood PCR has limited value because Borrelia can be sparse in blood, making false-negative results expected. It also frames a negative blood result as unable to speak for untested tissues, and even tissue PCR would not by itself prove viable persistent infection.

Verified conclusion

Blood PCR for Borrelia is a poor standalone test for either excluding Lyme infection or making claims about persistence in tissues.

Clinical evidence

  • Borrelia burgdorferi enters the bloodstream transiently and in low numbers, limiting the amount of DNA available in a routine blood specimen. Reported plasma/whole-blood PCR sensitivity is commonly about 30–50% (individual studies roughly 34–62%); a prospective untreated erythema-migrans cohort detected plasma DNA in only 14/76 patients (18.4%). Reviews have reported median blood/plasma/serum sensitivity near 14%.
  • Therefore, a negative blood PCR is compatible with true infection, particularly early disease or disease localized to skin, joints, or neurologic tissue. It is not an adequate rule-out test.

Mechanistic and tissue interpretation

  • False-negative blood results are biologically expected when spirochetemia is intermittent, organism burden is below the assay’s detection threshold, or organisms are concentrated outside the vascular compartment. Timing, sampled blood volume, specimen matrix, processing, and assay design further affect yield.
  • A negative result means only that target DNA was not detected in that blood sample at that time. It cannot be extrapolated to anatomically distinct, untested tissues. Incomplete concordance between blood and skin testing, and detection of Borrelia DNA in synovial membrane despite negative synovial fluid, illustrate this limitation.
  • Conversely, PCR positivity in tissue detects nucleic acid, not necessarily viable or replicating organisms; it alone cannot establish active persistent infection.

Clinical implications

  • Guidelines do not recommend blood PCR as routine Lyme testing. Typical erythema migrans is diagnosed clinically; serology is generally preferred for other presentations, while synovial PCR has a selective role in seropositive suspected Lyme arthritis.

Bottom line

  • The claim is well supported: negative blood Borrelia PCR neither excludes infection nor demonstrates absence or persistence of organisms in tissue.

References

  1. AAN/ACR/IDSA 2020 Guidelines for the Prevention, Diagnosis and ... — idsociety.org ↗
  2. Supplement Materials for the IDSA/AAN/ACR 2020 Draft Lyme Disease Guidelines — assets.contentstack.io ↗
  3. Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States — wwwnc.cdc.gov ↗
  4. The Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American Research — scienceopen.com ↗
  5. Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  6. Diagnosis of Lyme Borreliosis - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  7. Burden and viability of Borrelia burgdorferi in skin ... - PubMed - NIH — pubmed.ncbi.nlm.nih.gov ↗
  8. Biodiversity of Borrelia burgdorferi Strains in Tissues of — journals.plos.org ↗
  9. Clinical Practice Guidelines by the Infectious Diseases Society ... — academic.oup.com ↗
  10. CLINICAL MICROBIOLOGY REVIEWS, — ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes a negative blood PCR rule out Lyme borreliosis?→Plausible5 sourcesDoes a negative blood PCR or positive antibody test rule out or confirm active Borrelia infection?→